James Streisand
Keine laufenden Positionen mehr
Karriereverlauf von James Streisand
Ehemalige bekannte Positionen von James Streisand
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Sanofi SA | Corporate Officer/Principal | 01.04.2011 | 01.06.2013 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.1998 | 01.04.2011 |
| REVO BIOLOGICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 | - |
Ausbildung von James Streisand
| Massachusetts Institute of Technology | Undergraduate Degree |
| State University of New York at Buffalo | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
| Sanofi SA | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- James Streisand
- Erfahrung
